Novartis traded at 80.91 this Tuesday July 5th, decreasing 0.74 or 0.91 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 5.84 percent. Over the last 12 months, its price fell by 4.31 percent. Looking ahead, we forecast Novartis to be priced at 78.26 by the end of this quarter and at 72.36 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
80.91
Daily Change
-0.91%
Yearly
-4.31%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.31 -0.49 -0.32% 32.47%
Alcon AG 67.84 -0.12 -0.18% 3.92%
Almirall SA 10.87 0.08 0.74% -28.01%
Amgen 245.83 0.28 0.11% 0.89%
Artemis Alpha 298.00 1.46 0.49% -33.18%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Bayer 55.52 -1.72 -3.00% 9.55%
Biogen 212.05 1.42 0.67% -38.52%
Bristol-Myers Squibb 75.74 -1.10 -1.43% 13.64%
Fresenius Medical Care 47.26 -0.40 -0.84% -30.19%
Fresenius 28.53 -0.79 -2.69% -34.89%
Genmab 2,407.00 54.00 2.29% -8.41%
Gilead Sciences 62.32 -0.04 -0.06% -8.90%
Galapagos 54.90 1.84 3.47% -5.08%
GRIFOLS 17.56 -0.28 -1.54% -21.61%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
J&J 177.50 -2.02 -1.13% 5.67%
Eli Lilly 324.99 0.28 0.09% 38.05%
Lonza Group 529.60 4.80 0.91% -20.46%
Merck 167.85 2.45 1.48% 1.39%
Merck & Co 92.26 -0.16 -0.17% 18.12%
Novartis 80.91 -0.74 -0.91% -4.31%
Orion 43.72 0.97 2.27% 17.97%
Pfizer 51.28 -1.04 -1.98% 30.50%
Philips 20.07 -0.08 -0.37% -50.12%
Recordati 42.91 -0.11 -0.26% -14.35%
Regeneron Pharmaceuticals 593.47 -1.93 -0.32% 1.93%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Sanofi 97.12 -1.22 -1.24% 11.93%
UCB 82.60 -0.04 -0.05% -6.92%

Indexes Price Day Year
CH20 10799 -179.47 -1.65% -9.75%

Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.